
Passion IT Framework
New research: Drug for common bowel disorder found to blunt Covid-19 vaccine response
- ByPassionIT News --
- 2021-04-27
People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of Covid-19 vaccine, say the authors of a large-scale study that found many had poor antibody responses.
Read More at:
https://indianexpress.com/article/explained/covid-vaccination-bowel-disorder-drug-research-7290849/
Related News
IRDAI proposes allowing insurers to invest in unlisted firms: sources
Thursday, 01 Jan, 1970
IRDAI proposes allowing insurers to invest in unlisted firms: sources
Thursday, 01 Jan, 1970
Tulsa, NWA stakeholders start angel investing program
Thursday, 01 Jan, 1970
Comment